Menstrual fluid factors facilitate tissue repair: identification and functional action in endometrial and skin repair.


Journal

FASEB journal : official publication of the Federation of American Societies for Experimental Biology
ISSN: 1530-6860
Titre abrégé: FASEB J
Pays: United States
ID NLM: 8804484

Informations de publication

Date de publication:
01 2019
Historique:
pubmed: 24 7 2018
medline: 10 7 2019
entrez: 24 7 2018
Statut: ppublish

Résumé

Repair after damage is essential for tissue homeostasis. Postmenstrual endometrial repair is a cyclical manifestation of rapid, scar-free, tissue repair taking ∼3-5 d. Skin repair after wounding is slower (∼2 wk). In the case of chronic wounds, it takes months to years to restore integrity. Herein, the unique "rapid-repair" endometrial environment is translated to the "slower repair" skin environment. Menstrual fluid (MF), the milieu of postmenstrual endometrial repair, facilitates healing of endometrial and keratinocyte "wounds" in vitro, promoting cellular adhesion and migration, stimulates keratinocyte migration in an ex vivo human skin reconstruct model, and promotes re-epithelialization in an in vivo porcine wound model. Proteomic analysis of MF identified a large number of proteins: migration inhibitory factor, neutrophil gelatinase-associated lipocalin, follistatin like-1, chemokine ligand-20, and secretory leukocyte protease inhibitor were selected for further investigation. Functionally, they promote repair of endometrial and keratinocyte wounds by promoting migration. Translation of these and other MF factors into a migration-inducing treatment paradigm could provide novel treatments for tissue repair.-Evans, J., Infusini, G., McGovern, J., Cuttle, L., Webb, A., Nebl, T., Milla, L., Kimble, R., Kempf, M., Andrews, C. J., Leavesley, D., Salamonsen, L. A. Menstrual fluid factors facilitate tissue repair: identification and functional action in endometrial and skin repair.

Identifiants

pubmed: 30036086
doi: 10.1096/fj.201800086R
doi:

Substances chimiques

Proteome 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

584-605

Auteurs

Jemma Evans (J)

The Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Department of Molecular and Translational Medicine, Monash University, Clayton, Victoria, Australia.

Giuseppe Infusini (G)

Walter and Eliza Hall Institute, Parkville, Victoria, Australia.

Jacqui McGovern (J)

Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.

Leila Cuttle (L)

Centre for Children's Burns and Trauma Research, School of Biomedical Sciences, Institute of Health and Biomedical Innovation at Centre for Children's Health Research, Queensland University of Technology, Brisbane, Queensland, Australia.

Andrew Webb (A)

Walter and Eliza Hall Institute, Parkville, Victoria, Australia.

Thomas Nebl (T)

Walter and Eliza Hall Institute, Parkville, Victoria, Australia.

Liz Milla (L)

Walter and Eliza Hall Institute, Parkville, Victoria, Australia.

Roy Kimble (R)

Centre for Children's Burns and Trauma Research, Centre for Children's Health Research, The University of Queensland, South Brisbane, Queensland, Australia; and.

Margit Kempf (M)

Centre for Children's Burns and Trauma Research, Centre for Children's Health Research, The University of Queensland, South Brisbane, Queensland, Australia; and.

Christine J Andrews (CJ)

Centre for Children's Burns and Trauma Research, Centre for Children's Health Research, The University of Queensland, South Brisbane, Queensland, Australia; and.

David Leavesley (D)

Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
Skin Research Institute of Singapore, Singapore.

Lois A Salamonsen (LA)

The Hudson Institute of Medical Research, Clayton, Victoria, Australia.
Department of Molecular and Translational Medicine, Monash University, Clayton, Victoria, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH